Asian-Americans develop type 2 diabetes at lower BMI than the general population...

The link between obesity and diabetes possibly uncovered...

Patients on PPAR-gamma agonists advised to find suitable physical activity...

Risk found to be neutral, but duration of diabetes and increased risk of bone fracture need further study...

Higher cumulative doses and duration of glyburide may be associated with increased risk...

Prediabetes risk significantly increased, but diabetes risk yet to be determined...

New ultra-wide-field technology gives ophthalmologists opportunity to view 80% of retina...

Orbera is a non-surgical intragastric balloon device that has been used for weight loss outside of the United States for over 20 years. It is now FDA approved to be used in the United States. The device is indicated for weight reduction in obese patients with a BMI of 30 to 40 kg/m2 who have been unable to lose weight with diet and exercise. The non-surgical procedure takes about 30 minutes. See Item #4

Future study to focus on effect of continuous glucose changes in both maternal and fetal health...

A bacterial species common to both diseases increases arterial inflammation by altering gene expression.